Aspartate beta-hydroxylase domain containing 1 as a prognostic marker associated with immune infiltration in skin cutaneous melanoma

BACKGROUND: Skin cutaneous melanoma (SKCM) is an extremely malignant tumor and accounts for the majority of skin cancer deaths. Aspartate beta-hydroxylase domain containing 1 (ASPHD1) may participate in cancer progression through controlling α-ketoglutarate-dependent dioxygenases. However, its role...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Shiquan, Deng, Min, Wen, Juan, Chen, Xiaoyuan, Xu, Jiaqi, Liu, Yu, Wan, Huanhuan, Wang, Jin, Yan, Leping, He, Yong, Xu, Yunsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063950/
https://www.ncbi.nlm.nih.gov/pubmed/37004045
http://dx.doi.org/10.1186/s12885-023-10625-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063950/
https://www.ncbi.nlm.nih.gov/pubmed/37004045
http://dx.doi.org/10.1186/s12885-023-10625-8

Ejemplares similares